European Union - English - EMA (European Medicines Agency)

mediwound germany gmbh - proteolytic enzymes enriched in bromelain - debridement - preparations for treatment of wounds and ulcers - nexobrid is indicated for removal of eschar in adults with deep partial- and full-thickness thermal burns.

Israel - English - Ministry of Health

mediwound ltd. - concentrate of proteolytic enzymes enriched in bromelain - powder and gel - concentrate of proteolytic enzymes enriched in bromelain 2 g - bromelains - nexobrid is indicated for removal of eschar in adults with deep partial- andfull-thickness thermal burns.

Israel - English - Ministry of Health

mediwound ltd. - concentrate of proteolytic enzymes enriched in bromelain - powder and gel - concentrate of proteolytic enzymes enriched in bromelain 5 g - bromelains - nexobrid is indicated for removal of eschar in adults with deep partial- andfull-thickness thermal burns.

United States - English - NLM (National Library of Medicine)

kmtr co., ltd. - silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4) - relieve atopic symptom (itching, inflammation and pain), relieve ring worm, relieve stress apply on evertox per 100 liter approximately application part: whole body apply for 5~30 minutes preferably during bath keep cool and dry after use

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxycillin trihydrate; amoxycillin -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - amoxycillin sodium -

Israel - English - Ministry of Health

cts ltd - ferrous as iron iii hydroxide sucrose complex - solution for injection - ferrous as iron iii hydroxide sucrose complex 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - venofer is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb, serum ferritin, tsat, serum iron, etc.)(hb haemoglobin, tsat transferrin saturation)

Israel - English - Ministry of Health

cts ltd - ferrous as iron iii hydroxide sucrose complex - solution for injection - ferrous as iron iii hydroxide sucrose complex 100 mg / 5 ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - venofer is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb, serum ferritin, tsat, serum iron, etc.)(hb haemoglobin, tsat transferrin saturation)

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - iron sucrose - solution for injection - iron sucrose 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - ferrovin is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb (haemoglobin),serum ferritin, tsat (transferrin saturation), serum iron, etc.).

Israel - English - Ministry of Health

teva israel ltd - benzocaine; bismuth oxychloride; menthol; thymol biiodide; zinc oxide - ointment - zinc oxide 10 %w/w; benzocaine 4 %w/w; menthol 0.25 %w/w; bismuth oxychloride 8 %w/w; thymol biiodide 2 %w/w - bismuth preparations, combinations - bismuth preparations, combinations - symptomatic relief of pain and discomfort in irritated anorectal tissues in: hemorrhoids, proctitis, papillitis, cryptitis, fissures and following anorectal surgery.